CT-95 in Advanced Cancers Associated With Mesothelin Expression | MicrobiomeTrials← Back to trialsNCT06756035
CT-95 in Advanced Cancers Associated With Mesothelin Expression
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-03-31Est. Completion: 2026-12
Enrollment target: 70 participants Locations- Context Investigational Site, Denver, Colorado, United States
- Context Investigational Site, Chicago, Illinois, United States
- Context Investigational Site, Grand Rapids, Michigan, United States
- Context Investigational Site, Hackensack, New Jersey, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- Context Investigational Site, Philadelphia, Pennsylvania, United States
- Context Investigational Site, Nashville, Tennessee, United States
- Context Investigational Site, San Antonio, Texas, United States
- Context Investigational Site, San Antonio, Texas, United States
Other microbiome trials you might be interested in
ThymomaStomach NeoplasmsPancreatic NeoplasmsMesotheliomaBiliary Tract NeoplasmsMesothelin Expressing Neoplasms
Background:
* Malignant mesothelioma is a malignancy arising from the mesothelial cells of the pleura, peritoneum, peri…
Bethesda, United StatesEst. completion Jul 25, 2033
MesotheliomaNeoplasmsStomach NeoplasmsPancreatic Neoplasms
Ovarian Neoplasms
Lung Neoplasms
Thymus Neoplasms
Colonic Neoplasms
Background:
Mesothelioma is an aggressive cancer that grows in the linings of the body; this can include the membranes …
Bethesda, United StatesEst. completion Jun 1, 2034